↓ Skip to main content

Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study

Overview of attention for article published in World Journal of Surgical Oncology, February 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study
Published in
World Journal of Surgical Oncology, February 2012
DOI 10.1186/1477-7819-10-41
Pubmed ID
Authors

Chieh-Lin Teng, Wen-Li Hwang, Yi-Ju Chen, Kuang-Hsi Chang, Shao-Bin Cheng

Abstract

Orthotopic liver transplantation (OLT) is one of the most effective treatments for patients with hepatocellular carcinoma (HCC) within the Milan criteria. However, for patients beyond these criteria, the recurrence rate is higher and the prognosis is worse. Sorafenib is the only drug showing survival benefits in advanced HCC patients; however, its role in patients beyond the Milan criteria after OLT remains unclear and requires further investigation.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 4%
Germany 1 4%
Unknown 25 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 22%
Student > Postgraduate 4 15%
Student > Doctoral Student 4 15%
Student > Bachelor 3 11%
Other 2 7%
Other 6 22%
Unknown 2 7%
Readers by discipline Count As %
Medicine and Dentistry 17 63%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Philosophy 1 4%
Mathematics 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Other 0 0%
Unknown 6 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2012.
All research outputs
#15,055,021
of 18,796,975 outputs
Outputs from World Journal of Surgical Oncology
#827
of 1,666 outputs
Outputs of similar age
#101,488
of 133,836 outputs
Outputs of similar age from World Journal of Surgical Oncology
#8
of 15 outputs
Altmetric has tracked 18,796,975 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,666 research outputs from this source. They receive a mean Attention Score of 1.9. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 133,836 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.